Introduced
S. 4332
Introduced in Senate · April 30, 2026April 16 (
legislative day
, April 14), 2026
Ms. Hassan (for herself and Mr. Budd) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Medication Competition Act”.